4th Quarter - Report

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

Firm
Client
Income
—
Expenses
$230,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Manufacturing MAN

Microbeads - H.R. 4895/S. 2902 - Microbead-Free Waters Act of 2014. Would prohibit the distribution of cosmetic products containing synthetic plastic microbeads after January 1, 2018; all sections.

LobbyistCovered position, as disclosed
JOHN GAY —
TRAVIS GIBBONS —
LINDSAY A MORRIS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2902 (113th), H.R. 4895 (113th)

Alcohol and Drug Abuse ALC

Dextromethorphan - legislation related to reducing incidents of abuse of a common ingredient in over-the-counter cough and cold medications: dextromethorphan (Preventing Abuse of Cough Treatments Act, H.R. 3969/S. 644, all sections).

LobbyistCovered position, as disclosed
JOHN GAY —
TRAVIS GIBBONS —
LINDSAY A MORRIS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3969 (113th), S. 644 (113th)

Taxation/Internal Revenue Code TAX

Flexible spending arrangements (FSA) and health savings accounts (HSA) - H.R. 2835/S. 1647 - Restoring Access to Medication Act. Repeals prohibition in Patient Protection and Affordable Care Act (P.L. 111-148, P.L. 111-152) against use of flexible spending arrangement (FSA) and health savings account (HSA) funds on over-the-counter medications; all sections. H.R. 1248/S. 610 - Family Health Care Flexibility Act. Would also repeal prohibition in Patient Protection and Affordable Care Act (P.L. 111-148, P.L. 111-152) against use of flexible spending arrangement (FSA) and health savings account (HSA) funds on over-the-counter medications; all sections. Senate bill "Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act." Would renew and extend certain expired and expiring tax provisions for an additional year; all sections. Companion legislation not yet introduced in House.

LobbyistCovered position, as disclosed
JOHN GAY —
TRAVIS GIBBONS —
LINDSAY A MORRIS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 610 (113th), H.R. 2835 (113th), H.R. 1248 (113th), S. 1647 (113th)

Chemicals/Chemical Industry CHM

Toxic Substances Control Act of 1976 (P.L. 94-469) - S. 1009 - Chemical Safety Improvement Act. Modernize and update the Toxic Substances Control Act of 1976 (TSCA; P.L. 94-469) by allowing the Environmental Protection Agency (EPA) to prioritize consideration of chemicals based on risk and set minimum federal standards for chemical regulation; all sections. Potential House bill - Chemicals in Commerce Act. Modernize and update the Toxic Substances Control Act of 1976 (TSCA; P.L. 94-469) by allowing the Environmental Protection Agency (EPA) to prioritize consideration of chemicals based on risk and set minimum federal standards for chemical regulation; all sections (no bill number).

LobbyistCovered position, as disclosed
JOHN GAY —
TRAVIS GIBBONS —
LINDSAY A MORRIS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1009 (113th)

Food Industry (safety, labeling, etc.) FOO

Dietary Supplements - S. 1425 - Dietary Supplement Labeling Act. Expands registration requirements for dietary supplement manufacturing or processing facilities; requires development of a definition of "conventional food," including foods marketed as dietary supplements; all sections. H.R. 4771/S. 2012 - Designer Anabolic Steroid Control Act (DASCA). Food and Drug Administration (FDA) regulation of anabolic steroids; all sections. Became Public Law 113-260. Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues."

LobbyistCovered position, as disclosed
JOHN GAY —
TRAVIS GIBBONS —
LINDSAY A MORRIS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4771 (113th), S. 2012 (113th), S. 1425 (113th)

Pharmacy PHA

Pseudoephedrine Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). H.R. 4502 - Stop Meth Labs and Enhance Patient Access Act of 2014 (all sections). Would grant additional authority to the Drug Enforcement Administration (DEA) to grant exemptions to the provisions of the Combat Methamphetamine Epidemic Act of 2005 (P.L. 109-177). Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; Mandatory recall authority of the FDA; Rx-to-OTC Switch Supporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines. H.R. 4250/S. 2141 - Sunscreen Innovation Act. Would require FDA to approve or deny new sunscreen ingredient applications under the "time and extent" application (TEA) process within a certain timeframe after submission; all sections.

LobbyistCovered position, as disclosed
JOHN GAY —
TRAVIS GIBBONS —
LINDSAY A MORRIS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4502 (113th), S. 2141 (113th), H.R. 4250 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.